By Business/Source
Currency:USD
2019/FY
Stock NameRevenueRatio
Developing novel neuroplastogenic small-molecule therapeutics for the treatment of depression39.91M100.00%
By Country/Region
Currency:USD
2019/FY
Stock NameRevenueRatio
North America39.91M100.00%